SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-024075
Filing Date
2023-03-29
Accepted
2023-03-29 16:02:49
Documents
54
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_orionbiotech.htm   iXBRL 10-K 1138440
2 DESCRIPTION OF SECURITIES f10k2022ex4-1_orionbiotech.htm EX-4.1 252429
3 CERTIFICATION f10k2022ex31-1_orionbiotech.htm EX-31.1 10428
4 CERTIFICATION f10k2022ex31-2_orionbiotech.htm EX-31.2 10191
5 CERTIFICATION f10k2022ex32-1_orionbiotech.htm EX-32.1 4699
6 CERTIFICATION f10k2022ex32-2_orionbiotech.htm EX-32.2 4615
  Complete submission text file 0001213900-23-024075.txt   4439905

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE oria-20221231.xsd EX-101.SCH 49658
8 XBRL CALCULATION FILE oria-20221231_cal.xml EX-101.CAL 21208
9 XBRL DEFINITION FILE oria-20221231_def.xml EX-101.DEF 202051
10 XBRL LABEL FILE oria-20221231_lab.xml EX-101.LAB 364899
11 XBRL PRESENTATION FILE oria-20221231_pre.xml EX-101.PRE 210267
48 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_orionbiotech_htm.xml XML 294922
Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40410 | Film No.: 23775151
SIC: 6770 Blank Checks